Skip to content
Disclosery

SILVERBACK ASSET MANAGEMENT LLC

Follow

13F filer, CIK 1278960, DURHAM, NC

SILVERBACK ASSET MANAGEMENT LLC reported $924,757,638 across 64 holdings for the quarter ended 2026-06-30, in a 13F-HR filed 2026-08-13. Its ten largest share positions make up 46.16% of the portfolio.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001398344-26-014289

Period
2026-06-30
Reported value
$925M
Holdings
64
Top 10 weight
46.16%
New
21
Sold out
16

Largest buys vs the previous quarter

SecurityShares changeApprox. value
OCGNnew+250,000$382K
VRMadded+11,300$87K

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
HLITreduced-123,566-$2.02M
NEOexited-165,101-$1.23M
CORZreduced-29,300-$750K
STNGexited-10,000-$747K
MXreduced-120,000-$568K

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q2 2026

Share positions as resolved from 13F-HR 0001398344-26-014289, largest first. % of portfolio is the value over $790,660,512, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
HLITHARMONIC INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 712,023 shares; 2024Q4: 691,644 shares; 2025Q1: not reported; 2025Q2: 710,000 shares; 2025Q3: 674,600 shares; 2025Q4: 650,000 shares; 2026Q1: 648,566 shares; 2026Q2: 525,000 shares 525,000$8.57M1.08%-123,566Timeline
VRMVROOM INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 424,873 shares; 2025Q2: 423,132 shares; 2025Q3: 414,949 shares; 2025Q4: 425,488 shares; 2026Q1: 437,936 shares; 2026Q2: 449,236 shares 449,236$3.46M0.44%+11,300Timeline
CORZCORE SCIENTIFIC INC NEWQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 160,900 shares; 2026Q1: 160,900 shares; 2026Q2: 131,600 shares 131,600$3.37M0.43%-29,300Timeline
WULFTERAWULF INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 96,600 shares; 2026Q1: 96,600 shares; 2026Q2: 96,600 shares 96,600$2.39M0.3%0Timeline
ASTSAST SPACEMOBILE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 24,200 shares; 2026Q1: 24,200 shares; 2026Q2: 24,200 shares 24,200$2.15M0.27%0Timeline
AVAVAEROVIRONMENT INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 12,100 shares; 2026Q1: 12,100 shares; 2026Q2: 12,100 shares 12,100$2M0.25%0Timeline
TEMTEMPUS AI INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 24,700 shares; 2026Q1: 35,700 shares; 2026Q2: 28,700 shares 28,700$1.66M0.21%-7,000Timeline
LPSNLIVEPERSON INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 485,001 shares; 2026Q1: 485,001 shares; 2026Q2: 485,001 shares 485,001$922K0.12%0Timeline
EYPTEYEPOINT INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 50,000 shares; 2026Q2: 50,000 shares 50,000$715K0.09%0Timeline
MXMAGNACHIP SEMICONDUCTOR CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 220,000 shares; 2024Q4: 220,000 shares; 2025Q1: not reported; 2025Q2: 220,000 shares; 2025Q3: 220,000 shares; 2025Q4: 220,000 shares; 2026Q1: 220,000 shares; 2026Q2: 100,000 shares 100,000$473K0.06%-120,000Timeline
OCGNOCUGEN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 250,000 shares 250,000$382K0.05%newTimeline
ARAYACCURAY INC DELQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: 69,061 shares; 2025Q1: not reported; 2025Q2: 1,166,054 shares; 2025Q3: 1,066,054 shares; 2025Q4: 1,532,519 shares; 2026Q1: 1,650,000 shares; 2026Q2: 1,450,000 shares 1,450,000$374K0.05%-200,000Timeline
KPTIKARYOPHARM THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 70,000 shares; 2025Q3: 40,000 shares; 2025Q4: 40,000 shares; 2026Q1: 65,000 shares; 2026Q2: 30,000 shares 30,000$293K0.04%-35,000Timeline

Options

Puts and calls, as filed. The amount and value describe the underlying shares, not the option premium, so they stay out of % of portfolio (H5).

SecurityTypeAmountValueChange
IWMISHARES TR SHScall275,000$82.6M+175,000
DFTXDEFINIUM THERAPEUTICS INC COM SHScall294,400$13.8M0
CYTKCYTOKINETICS INC COM NEWcall100,000$8.52Mnew
XLVSELECT SECTOR SPDR TR SHScall50,000$7.93Mnew
XBISPDR SERIES TRUST S&P BIOTECHcall50,000$7.91Mnew
NTNXNUTANIX INC Stockcall100,000$5.1Mnew
LCIDLUCID GROUP INC Stockput470,000$3.14M0
PARPAR TECHNOLOGY CORP COMcall150,000$2.61M0
EYPTEYEPOINT INC Stockcall100,000$1.43M0
KPTIKARYOPHARM THERAPEUTICS INC COMMON STOCKcall100,000$977K0

Principal amounts

Notes and convertibles filed as a face amount (PRN). A face amount is never added to a share count (H6).

SecurityTypeAmountValueChange
SEMTECH CORPSEMTECH CORP NOTE 1.625%11/0principal17,674,000$76.7M+5,066,000
MKS INC.MKS INC. NOTE 1.250% 6/0principal14,700,000$43.3Mnew
AVNET INCAVNET INC NOTE 1.750% 9/0principal25,000,000$35.1Mnew
JAZZ INVESTMENTS I LTDJAZZ INVESTMENTS I LTD Convertibleprincipal20,034,000$34.2Mnew
INDIE SEMICONDUCTOR INCINDIE SEMICONDUCTOR INC NOTE 3.500% 12/1principal28,915,000$33.5M-7,600,000
CHEESECAKE FACTORY INCCHEESECAKE FACTORY INC NOTE 2.000% 3/1principal25,000,000$31.8Mnew
CYBERARK SOFTWARE LTDCYBERARK SOFTWARE LTD NOTE6/1principal18,150,000$30.2Mnew
WOLFSPEED INCWOLFSPEED INC NOTE 2.500% 6/1principal7,194,000$28.4M-1,337,000
CRACKER BARREL OLD CTRY STORCRACKER BARREL OLD CTRY STOR NOTE 1.750% 9/1principal25,879,000$26.5Mnew
PORCH GROUP INCPORCH GROUP INC DEBT 9.000% 5/1principal17,500,000$25.3M-1,000,000
UBER TECHNOLOGIES INCUBER TECHNOLOGIES INC NOTE 0.875%12/0principal20,000,000$24M-3,000,000
DROPBOX INCDROPBOX INC NOTE 3/0principal22,800,000$23M+5,000,000
NUTANIX INCNUTANIX INC Convertibleprincipal19,841,000$22.4M-2,159,000
BRIDGEBIO PHARMA INCBRIDGEBIO PHARMA INC Convertibleprincipal19,532,000$21.7M-2,500,000
ALPHATEC HLDGS INCALPHATEC HLDGS INC NOTE 0.750% 3/1principal22,028,000$21M+7,778,000
ORACLE CORPORACLE CORP 6.5 DEP CUM SR Dprincipal430,000$19.3M-60,000
COLLEGIUM PHARMACEUTICAL INCCOLLEGIUM PHARMACEUTICAL INC NOTE 2.875% 2/1principal15,298,000$18.8M+4,998,000
SYNAPTICS INCSYNAPTICS INC NOTE 0.750%12/0principal10,684,000$15.9M-9,739,000
ON SEMICONDUCTOR CORPON SEMICONDUCTOR CORP NOTE 0.500% 3/0principal12,000,000$14.5Mnew
HAEMONETICS CORP MASSHAEMONETICS CORP MASS NOTE 2.500% 6/0principal14,283,000$14.5M0
GUIDEWIRE SOFTWARE INCGUIDEWIRE SOFTWARE INC NOTE 1.250%11/0principal14,546,000$14M+2,046,000
GLOBAL PMTS INCGLOBAL PMTS INC NOTE 1.500% 3/0principal15,000,000$13.5Mnew
VARONIS SYS INCVARONIS SYS INC NOTE 1.000% 9/1principal13,455,000$13.1M-7,000,000
HALOZYME THERAPEUTICS INCHALOZYME THERAPEUTICS INC NOTE 0.250% 3/0principal11,134,000$12.4M0
CENTURY ALUM COCENTURY ALUM CO NOTE 2.750% 5/0principal5,000,000$12.3Mnew
PORCH GROUP INCPORCH GROUP INC NOTE/6 750% 10/1principal11,713,000$12.2M-5,500,000
ZSCALER INC.ZSCALER INC. NOTE 7/1principal12,633,000$11.7Mnew
A10 NETWORKS INCA10 NETWORKS INC NOTE 2.750% 4/0principal6,750,000$11.5Mnew
VERTEX INCVERTEX INC NOTE 0.750% 5/0principal12,500,000$11.2M-2,500,000
GOLAR LNG LTDGOLAR LNG LTD NOTE 2.750%12/1principal9,700,000$11Mnew
WOLFSPEED INCWOLFSPEED INC CONV BONDprincipal4,230,000$10.6Mnew
EVOLENT HEALTH INCEVOLENT HEALTH INC DEBT 4.500% 8/1principal13,518,000$10.6M-3,131,000
WOLFSPEED INCWOLFSPEED INC NOTE 2.5% 6/15/31principal2,610,000$10.3Mnew
VISHAY INTERTECHNOLOGY INCVISHAY INTERTECHNOLOGY INC NOTE 2.250% 9/1principal4,583,000$9.1M-24,250,000
WEC ENERGY GROUP INCWEC ENERGY GROUP INC NOTE 3.375% 6/0principal8,000,000$8.32Mnew
AKAMAI TECHNOLOGIES INCAKAMAI TECHNOLOGIES INC NOTE 0.375% 9/0principal6,499,000$7.8M+3,999,000
EVOLENT HEALTH INCEVOLENT HEALTH INC NOTE 3.500%12/0principal10,000,000$7.41M0
VIRIDIAN THERAPEUTICS INCVIRIDIAN THERAPEUTICS INC NOTE 1.750% 5/1principal6,495,000$6.97Mnew
OMNICELL COMOMNICELL COM NOTE 1.000%12/0principal5,600,000$5.95M-4,000,000
QIMONDA AGQIMONDA AG NOTE 6.750% 3/2principal12,400,000$3.22M0
INOTIV INCINOTIV INC Convertible Bondprincipal17,092,000$583K0

Sold out in Q2 2026

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
SPYSTATE STR SPDR S&P 500 ETF T150,000$97.6Mput
IWMISHARES TR155,000$38.4Mput
ON SEMICONDUCTOR CORPON SEMICONDUCTOR CORP22,571,000$29.1Mprincipal
IAC FinanceCo 2, Inc.IAC FinanceCo 2, Inc.24,603,000$24.4Mprincipal
Alnylam Pharmaceuticals IncAlnylam Pharmaceuticals Inc15,161,000$14.1Mprincipal
KIESPDR SERIES TRUST100,000$5.5Mput
KIESPDR SERIES TRUST100,000$5.5Mcall
AMPHASTAR PHARMACEUTICALS INAMPHASTAR PHARMACEUTICALS IN5,080,000$4.6Mprincipal
PENGUIN SOLUTIONS INCPENGUIN SOLUTIONS INC3,985,000$4Mprincipal
VIAVVIAVI SOLUTIONS INC100,000$3.33Mcall
BKLNINVESCO EXCH TRADED FD TR II112,100$2.29Mput
PELOTON INTERACTIVE INCPELOTON INTERACTIVE INC1,368,000$1.83Mprincipal
NEONEOGENOMICS INC165,101$1.23Mshares
STNGSCORPIO TANKERS INC10,000$747Kshares
INDIINDIE SEMICONDUCTOR INC100,000$322Kput
GOSSGOSSAMER BIO INC500,000$164Kcall

How Q2 2026 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001398344-26-014289 base2026-08-13acceptance time not in the bulk data set

Filings

Every filing of this filer: 13F reports and notices, the 13D and 13G it filed or is a reporting person of, and Forms 3, 4 and 5 it reported as an owner.

FilingSubjectFiledAcceptedIngested
13F-HR 0001398344-26-014289 Quarter ended 2026-06-302026-08-13acceptance time not in the bulk data set
13F-HR/A 0001398344-26-009537 Quarter ended 2026-03-312026-05-21acceptance time not in the bulk data set
13F-HR 0001398344-26-009154 Quarter ended 2026-03-312026-05-14acceptance time not in the bulk data set
13F-HR 0001398344-26-003233 Quarter ended 2025-12-312026-02-17acceptance time not in the bulk data set
13F-HR 0001398344-25-020867 Quarter ended 2025-09-302025-11-13acceptance time not in the bulk data set
13F-HR 0001398344-25-015245 Quarter ended 2025-06-302025-08-13acceptance time not in the bulk data set
13F-HR 0001398344-25-009555 Quarter ended 2025-03-312025-05-15acceptance time not in the bulk data set
13F-HR/A 0001398344-25-003673 Quarter ended 2024-12-312025-02-27acceptance time not in the bulk data set
13F-HR 0001398344-25-002704 Quarter ended 2024-12-312025-02-13acceptance time not in the bulk data set
13F-HR 0001398344-24-020823 Quarter ended 2024-09-302024-11-14acceptance time not in the bulk data set
13F-HR 0001398344-24-014664 Quarter ended 2024-06-302024-08-14acceptance time not in the bulk data set
13F-HR 0001398344-24-009376 Quarter ended 2024-03-312024-05-14acceptance time not in the bulk data set
13F-HR 0001398344-24-002722 Quarter ended 2023-12-312024-02-13acceptance time not in the bulk data set
13F-HR 0001398344-23-020653 Quarter ended 2023-09-302023-11-14acceptance time not in the bulk data set
13F-HR/A 0001398344-23-019049 Quarter ended 2023-06-302023-10-06acceptance time not in the bulk data set
13F-HR/A 0001398344-23-015107 Quarter ended 2023-06-302023-08-17acceptance time not in the bulk data set
13F-HR 0001398344-23-014784 Quarter ended 2023-06-302023-08-14acceptance time not in the bulk data set
13F-HR 0001398344-23-009761 Quarter ended 2023-03-312023-05-15acceptance time not in the bulk data set
13F-HR/A 0001398344-23-005308 Quarter ended 2022-09-302023-03-02acceptance time not in the bulk data set
13F-HR 0001398344-23-003214 Quarter ended 2022-12-312023-02-14acceptance time not in the bulk data set
13F-HR 0001398344-22-022129 Quarter ended 2022-09-302022-11-14acceptance time not in the bulk data set
13F-HR 0001398344-22-015602 Quarter ended 2022-06-302022-08-15acceptance time not in the bulk data set
13F-HR 0001398344-22-009485 Quarter ended 2022-03-312022-05-13acceptance time not in the bulk data set
13F-HR 0001398344-22-003038 Quarter ended 2021-12-312022-02-14acceptance time not in the bulk data set
13F-HR 0001398344-21-021523 Quarter ended 2021-09-302021-11-15acceptance time not in the bulk data set
13F-HR 0001398344-21-016301 Quarter ended 2021-06-302021-08-16acceptance time not in the bulk data set
13F-HR 0001398344-21-010927 Quarter ended 2021-03-312021-05-17acceptance time not in the bulk data set
13F-HR 0001398344-21-003552 Quarter ended 2020-12-312021-02-16acceptance time not in the bulk data set
13F-HR/A 0001398344-20-024957 Quarter ended 2020-09-302020-12-22acceptance time not in the bulk data set
13F-HR 0001398344-20-022602 Quarter ended 2020-09-302020-11-13acceptance time not in the bulk data set
13F-HR 0001398344-20-015826 Quarter ended 2020-06-302020-08-14acceptance time not in the bulk data set
13F-HR 0001398344-20-010037 Quarter ended 2020-03-312020-05-13acceptance time not in the bulk data set
13F-HR 0001398344-20-003236 Quarter ended 2019-12-312020-02-13acceptance time not in the bulk data set
13F-HR/A 0001398344-19-022038 Quarter ended 2019-09-302019-12-05acceptance time not in the bulk data set
13F-HR 0001398344-19-020337 Quarter ended 2019-09-302019-11-14acceptance time not in the bulk data set
13F-HR/A 0001398344-19-018789 Quarter ended 2019-06-302019-10-30acceptance time not in the bulk data set
13F-HR 0001398344-19-014272 Quarter ended 2019-06-302019-08-14acceptance time not in the bulk data set
13F-HR 0001398344-19-008898 Quarter ended 2019-03-312019-05-15acceptance time not in the bulk data set
13F-HR 0001398344-19-002781 Quarter ended 2018-12-312019-02-14acceptance time not in the bulk data set
13F-HR 0001398344-18-016517 Quarter ended 2018-09-302018-11-14acceptance time not in the bulk data set
13F-HR 0001398344-18-011771 Quarter ended 2018-06-302018-08-14acceptance time not in the bulk data set
13F-HR 0001398344-18-007375 Quarter ended 2018-03-312018-05-14acceptance time not in the bulk data set
13F-HR 0001398344-18-002040 Quarter ended 2017-12-312018-02-13acceptance time not in the bulk data set
13F-HR 0001398344-17-014622 Quarter ended 2017-09-302017-11-14acceptance time not in the bulk data set
13F-HR/A 0001398344-17-012076 Quarter ended 2017-06-302017-09-18acceptance time not in the bulk data set
13F-HR 0001398344-17-010221 Quarter ended 2017-06-302017-08-14acceptance time not in the bulk data set
13F-HR 0001398344-17-006282 Quarter ended 2017-03-312017-05-12acceptance time not in the bulk data set
13F-HR 0001398344-17-002014 Quarter ended 2016-12-312017-02-14acceptance time not in the bulk data set
13F-HR 0001398344-16-020641 Quarter ended 2016-09-302016-11-14acceptance time not in the bulk data set
13F-HR 0001398344-16-016671 Quarter ended 2016-06-302016-08-15acceptance time not in the bulk data set
13F-HR/A 0001398344-16-013467 Quarter ended 2016-03-312016-05-16acceptance time not in the bulk data set
13F-HR 0001398344-16-013355 Quarter ended 2016-03-312016-05-13acceptance time not in the bulk data set
13F-HR 0001398344-16-009939 Quarter ended 2015-12-312016-02-16acceptance time not in the bulk data set
13F-HR 0001398344-15-007616 Quarter ended 2015-09-302015-11-13acceptance time not in the bulk data set
13F-HR 0001398344-15-005221 Quarter ended 2015-06-302015-08-13acceptance time not in the bulk data set
13F-HR 0001398344-15-003257 Quarter ended 2015-03-312015-05-14acceptance time not in the bulk data set
13F-HR 0001398344-15-000970 Quarter ended 2014-12-312015-02-13acceptance time not in the bulk data set
13F-HR 0001398344-14-005882 Quarter ended 2014-09-302014-11-14acceptance time not in the bulk data set
13F-HR 0001398344-14-004138 Quarter ended 2014-06-302014-08-13acceptance time not in the bulk data set
13F-HR 0001398344-14-002725 Quarter ended 2014-03-312014-05-13acceptance time not in the bulk data set
13F-HR 0001398344-14-001081 Quarter ended 2013-12-312014-02-14acceptance time not in the bulk data set
13F-HR 0001398344-13-005371 Quarter ended 2013-09-302013-11-14acceptance time not in the bulk data set
13F-HR 0001398344-13-003815 Quarter ended 2013-06-302013-08-14acceptance time not in the bulk data set